Multi-Omics Integrative Analyses Identified Two Endotypes of Hip Osteoarthritis
Open Access
- 1 September 2024
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (9) , 480
Abstract
(1) Background: Osteoarthritis (OA) is a heterogeneous disorder, and subgroup classification of OA remains elusive. The aim of our study was to identify endotypes of hip OA and investigate the altered pathways in the different endotypes. (2) Methods: Metabolomic profiling and genome-wide genotyping were performed on fasting blood. Transcriptomic profiling was performed on RNA extracted from cartilage samples. Machine learning methods were used to identify endotypes of hip OA. Pathway analysis was used to identify the altered pathways between hip endotypes and controls. GWAS was performed on each of the identified metabolites. Transcriptomic data was used to examine the expression levels of identified genes in cartilage. (3) Results: 180 hip OA patients and 120 OA-free controls were classified into three clusters based on metabolomic data. The combination of arginine, ornithine, and the average value of 7 lysophosphatidylcholines had an area under the curve (AUC) of 0.97 (95% CI: 0.96–0.99) to discriminate hip OA from controls, and the combination of γ-aminobutyric acid, spermine, aconitic acid, and succinic acid had an AUC of 0.96 (95% CI: 0.94–0.99) to distinguish two hip OA endotypes. GWAS identified 236 SNPs to be associated with identified metabolites at GWAS significance level. Pro-inflammatory cytokine levels were significantly different between two endotypes (all p < 0.05). (4) Conclusions: Hip OA could be classified into two distinct molecular endotypes. The primary differences between the two endotypes involve changes in pro-inflammatory factors and energy metabolism.Keywords
Funding Information
- Canadian Institutes of Health Research (FRN#175015, 153298, 143058, 132178, 191966, MOP192552, 22-121, 5404.1423.102)
- Arthritis Society (FRN#175015, 153298, 143058, 132178, 191966, MOP192552, 22-121, 5404.1423.102)
- Research and Development Corporation of Newfoundland and Labrador (FRN#175015, 153298, 143058, 132178, 191966, MOP192552, 22-121, 5404.1423.102)
- Memorial University of Newfoundland Medical Research Fund (FRN#175015, 153298, 143058, 132178, 191966, MOP192552, 22-121, 5404.1423.102)
This publication has 60 references indexed in Scilit:
- Obesity defined molecular endotypes in the synovium of patients with osteoarthritis provides a rationale for therapeutic targeting of fibroblast subsetsClinical and Translational Medicine, 2023
- GABA regulates IL-1β production in macrophagesCell Reports, 2022
- Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokinesMetabolomics, 2022
- Structural phenotypes of knee osteoarthritis: potential clinical and research relevanceSkeletal Radiology, 2022
- HILPDA Uncouples Lipid Droplet Accumulation in Adipose Tissue Macrophages from Inflammation and Metabolic DysregulationCell Reports, 2020
- Metabolomics Signature for Non‐Responders to Total Joint Replacement Surgery in Primary Osteoarthritis Patients: The Newfoundland Osteoarthritis StudyJournal of Orthopaedic Research, 2019
- Changes in acetyl-CoA mediate Sik3-induced maturation of chondrocytes in endochondral bone formationBiochemical and Biophysical Research Communications, 2019
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndromeJournal of Allergy and Clinical Immunology, 2011
- Spermine Inhibition of Monocyte Activation and InflammationMolecular Medicine, 1999
- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis & Rheumatism, 1991